STOCK TITAN

Aptiv Plc Form 4 Filings

APTV NYSE

Every Form 4 that Aptiv Plc (APTV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow APTV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full APTV filings page.

Rhea-AI Summary

Aptiv PLC director Hakan Agnevall purchased 4,100 Ordinary Shares of APTV on 2026-08-13 in an open-market transaction at a weighted average price of $48.581 per share, with individual trade prices ranging from $48.54 to $48.64. Following this purchase, he directly holds 17,797 Ordinary Shares.

Rhea-AI Summary

Aptiv PLC Chair and CEO Kevin P. Clark reported a bona fide gift of 51,190 Ordinary Shares on 2026-08-12. The gift carried a stated price of $0.00 per share, reflecting a non-cash transfer rather than a market sale. Following this disposition, Clark directly holds 599,826 Ordinary Shares. He also reports indirect ownership of 778,400 Ordinary Shares held through the Kevin P Clark Revocable Trust. The filing does not indicate use of a Rule 10b5-1 trading plan.

Rhea-AI Summary

Aptiv PLC director Sean O. Mahoney reported open-market purchases of Aptiv ordinary shares on 2026-08-11 totaling 11,000 shares. He bought 4,000 shares directly at a weighted average price of $50.287, increasing his direct holdings to 24,514 shares. He also purchased 6,000 shares through the Sean Mahoney Defined Benefit Pension Plan & Trust at a weighted average price of $50.2092, and 1,000 shares through the Sean Mahoney Incentive Savings Plan & Trust at $50.28. Footnotes state the reported prices are weighted averages based on multiple trades within disclosed price ranges.

Rhea-AI Summary

Aptiv PLC Chair and CEO Kevin P. Clark purchased 51,190 Ordinary Shares on August 10, 2026 in an open-market or private transaction at a weighted average price of $48.8901 per share, with individual trade prices ranging from $48.81 to $48.90. Following this purchase, Clark directly holds 651,016 Ordinary Shares and indirectly holds 727,210 Ordinary Shares through the Kevin P. Clark Revocable Trust. The transaction was not made pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

Aptiv PLC director Paul M. Meister, through the Woburn Abbey March 2021 Trust GST Exempt Share, purchased 105,631 Ordinary Shares on August 5, 2026 at $47.3342 per share. After this trade, the trust holds 105,631 shares, with additional holdings of 13,612 shares directly and 19,181 shares through another trust.

Rhea-AI Summary

Aptiv PLC reported that SVP & Chief Accounting Officer Allan J. Brazier had 4,062 Ordinary Shares withheld on 2026-07-14 at $58.06 per share to cover tax liabilities from vesting restricted stock units. After this tax-withholding disposition, he holds 63,323 Ordinary Shares directly.

Rhea-AI Summary

Aptiv PLC executive Obed D. Louissaint reported an open-market sale of 3,000 Ordinary Shares at $69.60 per share. The transaction took place on June 15, 2026, and was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.

Following this sale, Louissaint directly holds 210,803 Aptiv Ordinary Shares, indicating he retains a substantial ongoing equity stake in the company despite the disposition.

Rhea-AI Summary

Aptiv PLC executive Katherine H. Ramundo sold 2,000 Ordinary Shares in an open-market transaction. The sale occurred on June 3, 2026 at a price of $78.30 per share. After this trade, she directly holds 163,752 Ordinary Shares.

The transaction was carried out under a pre-established Rule 10b5-1 trading plan adopted on February 7, 2026, indicating it was pre-planned rather than a discretionary market-timing decision.

Rhea-AI Summary

Aptiv PLC director Hakan Agnevall reported an open-market purchase of Ordinary Shares. On May 8, 2026, he bought 6,100 shares at a weighted average price of $57.73 per share, through multiple trades between $57.69 and $57.79. After this transaction, he directly owns 13,697 Aptiv shares.

Rhea-AI Summary

Aptiv PLC director Ana G. Pinczuk reported routine equity compensation and related tax withholding. On April 29, 2026, she received 3,086 Ordinary Shares at $0.00 per share as a grant of restricted stock units under Aptiv’s Long Term Incentive Plan. A footnote states these restricted stock units each represent a right to receive one ordinary share and will vest in full one day before Aptiv’s Annual Meeting of Shareholders in 2027. On April 28, 2026, 287 Ordinary Shares were withheld at $59.12 per share to cover tax liabilities from the vesting of restricted stock units, which is not an open-market sale. Following these transactions, she held 13,314 Ordinary Shares directly and 15,561 Ordinary Shares indirectly through the Vaziri Pinczuk Living Trust.

Rhea-AI Summary

Aptiv PLC director Colin J. Parris reported routine equity compensation activity. He received a grant or award of 3,292 ordinary shares on April 29, 2026, bringing his direct holdings to 22,791 shares.

On April 28, 2026, 306 ordinary shares valued at $59.12 per share were withheld to cover tax liabilities tied to the vesting of restricted stock units, rather than sold in the market. A footnote also notes an adjustment to outstanding awards following the spin-off of Versigent PLC and confirms additional restricted stock units that will vest in full one day before Aptiv’s 2027 Annual Meeting of Shareholders.

Rhea-AI Summary

Aptiv PLC director Robert Kelly Ortberg reported equity compensation grants and related tax withholding. On April 29, 2026, he acquired 3,086 ordinary shares at $0.00 per share as a grant. On April 28, 2026, 287 ordinary shares were disposed of at $59.12 per share to satisfy tax liabilities from vesting restricted stock units, rather than through an open-market sale.

Following these transactions, he directly holds 19,448 ordinary shares. Footnotes note that outstanding awards were adjusted due to the spin-off of Versigent PLC and that he has restricted stock units under Aptiv’s Long Term Incentive Plan that will vest in full one day before the company’s 2027 Annual Meeting of Shareholders.

Rhea-AI Summary

Aptiv PLC director Paul M. Meister reported routine equity compensation activity. He received a grant of 6,344 ordinary shares as a share-based award, bringing his directly held stake to 13,612 shares. In a related tax event, 590 shares were withheld at $59.12 per share to cover tax liabilities tied to vesting restricted stock units, which reduced his direct holdings to 7,268 shares before the new grant.

Meister also reports indirect ownership of 19,181 ordinary shares through the Paul M. Meister 2005 Revocable Trust. Footnotes state that his restricted stock units each represent a right to receive one ordinary share and will vest in full one day before Aptiv’s 2027 Annual Meeting of Shareholders.

Rhea-AI Summary

Aptiv PLC director Sean O. Mahoney reported routine equity compensation activity. On 2026-04-29, he acquired 3,292 ordinary shares at $0.00 per share as a grant or award, bringing his direct holdings to 20,514 shares.

On 2026-04-28, 408 ordinary shares valued at $59.12 per share were disposed of to cover tax liabilities tied to vesting restricted stock units, a non-market transaction. Footnotes note that his outstanding awards were adjusted for the spin-off of Versigent PLC and that restricted stock units granted under Aptiv’s Long Term Incentive Plan will vest in full one day before the 2027 annual meeting.

Rhea-AI Summary

Aptiv PLC director Merit E. Janow reported routine equity compensation activity. On April 29, 2026, she acquired 3,086 ordinary shares at $0.00 per share as a grant or award, bringing her direct holdings to 13,804 ordinary shares following that transaction.

On April 28, 2026, 287 ordinary shares were disposed of at $59.12 per share to cover tax liabilities related to vesting restricted stock units. Footnotes state she has additional restricted stock units, each representing one ordinary share, that will vest in full one day before Aptiv's Annual Meeting of Shareholders in 2027 under the company's Long Term Incentive Plan.

Rhea-AI Summary

Aptiv PLC director Vasumati P. Jakkal reported routine equity compensation and related tax withholding in Aptiv ordinary shares. On April 29, 2026, she received 4,115 ordinary shares as a grant, bringing her direct holdings to 12,049 shares. These restricted stock units each represent a right to receive one ordinary share and will vest in full one day before Aptiv’s Annual Meeting of Shareholders in 2027 under the company’s Long Term Incentive Plan. On April 28, 2026, 383 shares were withheld at $59.12 per share to cover tax liabilities from vesting, a non-market disposition mechanism rather than an open-market sale.

Rhea-AI Summary

Aptiv PLC director Joseph L. Hooley reported routine equity compensation activity. On April 29, 2026, he acquired 5,572 Ordinary Shares at $0.00 per share as a grant under the company’s Long Term Incentive Plan, bringing his direct holdings to 27,869 shares.

On April 28, 2026, 518 Ordinary Shares were disposed of at $59.12 per share to cover tax liabilities related to vesting restricted stock units. Footnotes note that outstanding awards were adjusted for the spin-off of Versigent PLC and that additional restricted stock units will vest one day before the 2027 Annual Meeting.

Rhea-AI Summary

Aptiv PLC director Nancy E. Cooper reported routine equity compensation activity. On April 29, 2026, she received a grant of 3,395 Ordinary Shares at $0.00 per share as part of her board compensation, bringing her direct holdings to 20,406 shares.

On April 28, 2026, 316 Ordinary Shares were disposed of at $59.12 per share solely to cover tax liabilities related to the vesting of restricted stock units, a non-market, tax-withholding transaction. A footnote notes that outstanding awards were adjusted following the spin-off of Versigent PLC and that her restricted stock units under Aptiv's Long Term Incentive Plan will vest in full one day before the 2027 Annual Meeting of Shareholders.

Rhea-AI Summary

Aptiv PLC director Hakan Agnevall reported routine equity compensation and related tax withholding. On April 29, 2026, he acquired 3,086 Ordinary Shares at $0.00 per share as a grant, increasing his direct holdings to 7,597 shares. On April 28, 2026, 271 shares at $59.12 per share were disposed of to cover tax liabilities tied to restricted stock unit vesting, leaving 4,511 shares immediately after that event. Footnotes note the adjustment of outstanding awards following the spin-off of Versigent PLC and that his restricted stock units will vest in full one day before Aptiv’s 2027 Annual Meeting.

Rhea-AI Summary

Aptiv PLC executive Katherine H. Ramundo, EVP, CLO, CCO & Secretary, reported equity compensation awards in the form of ordinary shares. She was granted 28,179 ordinary shares and a separate 18,786-share award, both recorded at zero purchase price as grants rather than open-market purchases.

Footnotes state one award will vest in three equal installments beginning on February 28, 2027, and that totals reflect adjustments to outstanding awards related to the spin-off of Versigent PLC. Another award consists of performance shares that may convert into ordinary shares based on specified performance criteria over a period from January 1, 2026 to December 31, 2028.

Rhea-AI Summary

Massaro Joseph R reported acquisition or exercise transactions in this Form 4 filing.

Aptiv PLC reported that Vice Chair & President, EC Joseph R. Massaro received two equity awards of ordinary shares as compensation. On April 22, 2026, he was granted 62,898 ordinary shares at no cost and a separate award of 41,933 ordinary shares, also at no cost.

The filing notes that some of these shares will vest in three equal installments beginning on February 28, 2027, and that certain performance shares are contingent on achieving specified performance criteria over a period from January 1, 2026 to December 31, 2028.

Rhea-AI Summary

Aptiv PLC reported that EVP & Chief People Officer Obed D. Louissaint acquired equity-based compensation in the form of ordinary shares. He received grants of 34,216 and 22,812 ordinary shares at a stated price of $0.00 per share, reflecting stock awards rather than open-market purchases.

According to the footnotes, one award will vest in three equal installments beginning on February 28, 2027. Another award is structured as performance shares, each representing a contingent right to receive one ordinary share, which will vest based on specified performance criteria over a performance period from January 1, 2026 to December 31, 2028. These transactions increase his direct holdings and represent routine executive compensation, not market trading activity.

Rhea-AI Summary

Aptiv PLC EVP & Chief Financial Officer Varun Laroyia reported two share-based award grants. He acquired 42,771 ordinary shares as a grant that will vest in three equal installments beginning on February 28, 2027.

He also acquired 28,514 performance shares, each representing a contingent right to receive one ordinary share of Aptiv PLC. These performance shares will vest based on specified performance criteria measured over a performance period from January 1, 2026 to December 31, 2028. Following these awards, he holds 230,962 ordinary shares directly. Total reported awards also reflect adjustments related to the spin-off of Versigent PLC.

Rhea-AI Summary

CLARK KEVIN P reported acquisition or exercise transactions in this Form 4 filing.

Aptiv PLC Chair and CEO Kevin P. Clark received new equity awards in the form of ordinary shares. He was granted 145,924 shares and an additional 97,283 shares at no cash cost, increasing his directly held stake to 599,826 shares.

Separately, 727,210 shares are held indirectly through the Kevin P. Clark Revocable Trust. According to the footnotes, some of these awards will vest in three equal installments beginning on February 28, 2027, and certain performance shares vest based on performance criteria over a period from January 1, 2026 to December 31, 2028.

Rhea-AI Summary

Brazier Allan J reported acquisition or exercise transactions in this Form 4 filing.

Aptiv PLC disclosed that SVP & Chief Accounting Officer Allan J. Brazier received equity awards totaling 15,096 ordinary shares on April 22, 2026. These were granted as compensation at no cash cost to him. The awards include time-based shares that vest in three equal installments beginning on February 28, 2027, and performance shares that may vest based on specified performance criteria over a period from January 1, 2026 to December 31, 2028. The filing reflects routine equity compensation rather than open-market buying or selling.

Rhea-AI Summary

Aptiv PLC executive Joseph R. Massaro reported two equity-related transactions in ordinary shares. He acquired 13,772 shares at $0.00 per share as a grant tied to performance above target for the 2023–2025 performance period. He then disposed of 31,568 shares at $73.54 per share to cover tax liabilities from vesting restricted stock units. After these transactions, he directly owned 311,596 ordinary shares.

Rhea-AI Summary

Aptiv PLC executive Javed A. Khan, EVP and President, Software and AS&UX, reported a tax-related share disposition. On February 28, 2026, 5,875 Ordinary Shares were withheld at $73.54 per share to pay tax liabilities tied to vesting restricted stock units. After this tax-withholding disposition, he directly owned 192,371 Ordinary Shares. This was an administrative withholding rather than an open‑market sale.

Rhea-AI Summary

Aptiv PLC executive Louissaint Obed D., EVP & Chief People Officer, reported equity-related transactions in company ordinary shares. He acquired 7,186 shares at $0.00 per share as a grant tied to performance above target for the 2023-2025 period. In a separate move, 17,315 shares were disposed of at $73.54 per share to cover tax liabilities from restricted stock unit vesting, rather than an open-market sale. Following these transactions, he held 144,742 ordinary shares directly.

Rhea-AI Summary

Aptiv PLC executive Katherine H. Ramundo reported equity compensation activity involving the company’s ordinary shares. She acquired 5,509 shares on February 28, 2026 as a grant tied to performance above target for the 2023–2025 period, at a stated price of $0.0000 per share. On the same date, 13,160 shares were disposed of at $73.54 per share to cover tax liabilities triggered by the vesting of restricted stock units. After these transactions, she directly owned 109,308 ordinary shares.

Rhea-AI Summary

Aptiv PLC senior vice president and chief accounting officer Allan J. Brazier reported routine equity compensation activity involving the company’s ordinary shares. He acquired 1,437 shares on February 28, 2026 at a stated price of $0.0000 per share through a grant classified as a “grant, award, or other acquisition.” A footnote explains these additional shares were earned by achieving performance for the 2023–2025 period in excess of target. On the same date, 3,385 shares were disposed of at $73.5400 per share in a transaction coded as a tax-withholding disposition, with a footnote stating the shares were withheld to cover tax liabilities tied to vesting restricted stock units. After these transactions, Brazier directly owned 47,872 ordinary shares.

Rhea-AI Summary

Aptiv PLC executive Varun Laroyia, EVP & Chief Financial Officer, reported a tax-related share disposition. On the transaction date, 8,626 ordinary shares were withheld at $73.54 per share to cover tax liabilities from vesting restricted stock units. After this, he directly owned 142,143 ordinary shares.

Rhea-AI Summary

Aptiv PLC executive Joseph T. Liotine reported a tax-related share disposition. On this Form 4, 5,296 Ordinary Shares were withheld at a price of $73.54 per share to cover tax liabilities tied to the vesting of restricted stock units. After this withholding, he holds 143,912 Ordinary Shares directly.

Rhea-AI Summary

Aptiv PLC’s Chair and CEO Kevin P. Clark reported multiple share movements involving Aptiv ordinary shares. On March 3, 2026, he made a bona fide gift transfer of 83,988 ordinary shares, leaving him with 315,006 ordinary shares held directly afterward.

On February 28, 2026, he received a grant/award acquisition of 31,137 ordinary shares at no cost, tied to performance criteria for the 2023–2025 period, and 80,115 shares were disposed of to satisfy tax liabilities at $73.54 per share through share withholding. As of that date, he also had 727,210 ordinary shares held indirectly through the Kevin P. Clark Revocable Trust.

Rhea-AI Summary

Aptiv PLC executive Katherine H. Ramundo, who serves as EVP, CLO, CCO & Secretary, reported selling 5,000 ordinary shares of Aptiv on January 8, 2026 at a price of $85 per share. After this sale, she directly owned 116,959 ordinary shares.

The filing notes that these sales were carried out under a pre-arranged Rule 10b5-1 trading plan that she adopted on August 12, 2025, indicating the trades were made according to a preset schedule rather than as discretionary market timing.

Rhea-AI Summary

Aptiv PLC executive vice president and chief financial officer Varun Laroyia reported selling 5,000 ordinary shares on 12/12/2025 at $80.05 per share. The transaction was reported as a disposition and left him with 150,769 shares held directly. The sales were carried out under a Rule 10b5-1 trading plan that he adopted on 09/04/2025, which is a pre-arranged program for buying or selling shares.

Rhea-AI Summary

Aptiv PLC reported an insider transaction by Chair and CEO Kevin P. Clark, who is also a director. On 12/12/2025, he disposed of 25,320 ordinary shares at a price of $0 per share from an indirect holding through the Kevin P Clark Revocable Trust.

Following this transaction, he beneficially owned 643,222 ordinary shares indirectly through the trust and 447,972 ordinary shares directly.

Rhea-AI Summary

Aptiv PLC director Hakan Agnevall reported buying 3,700 ordinary shares of Aptiv on 12/12/2025 at a weighted average price of $80.248 per share.

After this transaction, he beneficially owns 4,655 Aptiv shares directly. The purchase was executed through multiple trades at prices ranging from $80.00 to $80.64 per share, according to the accompanying footnote.

Rhea-AI Summary

Aptiv PLC reported an insider equity award for a company director. On 12/10/2025, the director acquired 955 ordinary shares of Aptiv through a grant of restricted stock units at a stated price of $0 per share. Following this transaction, the director beneficially owns 955 ordinary shares, held directly.

The restricted stock units were granted under Aptiv’s Long Term Incentive Plan and each unit represents the right to receive one ordinary share. The award is scheduled to vest in full one day before Aptiv’s Annual Meeting of Shareholders in 2026, aligning the director’s equity compensation with that meeting date.

Rhea-AI Summary

Aptiv PLC reported an insider stock transaction by its EVP & Chief Financial Officer, Varun Laroyia. On December 4, 2025, he sold 14,500 ordinary shares of Aptiv at a price of $77.88 per share. The filing states that these sales were made under a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), which Laroyia adopted on September 4, 2025. Following this transaction, he beneficially owns 155,769 ordinary shares, held directly.

Rhea-AI Summary

Aptiv PLC director reports an open-market share sale. On December 5, 2025, a director of Aptiv PLC (APTV) sold 7,881 ordinary shares at a price of $76.60 per share in a transaction coded "S," which indicates a sale. After this transaction, the director beneficially owned 17,154 ordinary shares, held directly.

The filing notes that the reported sales were made under a Rule 10b5-1 trading plan adopted on September 5, 2025, which is a pre-arranged plan that allows insiders to sell stock according to preset instructions, helping separate trading decisions from day-to-day nonpublic information.

Rhea-AI Summary

Aptiv PLC reported an insider equity transaction by its EVP & Chief Financial Officer, Varun Laroyia. On 11/14/2025, a Form 4 shows a disposition of 12,446 ordinary shares of Aptiv at a price of $78.91 per share under transaction code “F.” This code indicates the shares were withheld by the company to cover tax liabilities related to the vesting of restricted stock units, rather than an open-market sale. After this tax withholding event, Laroyia directly beneficially owns 170,269 Aptiv ordinary shares.

Rhea-AI Summary

Aptiv PLC (APTV) disclosed an insider transaction on a Form 4. Director Sean O. Mahoney reported a transaction coded “G” (gift) of 310 ordinary shares on 11/12/2025 at a reported price of $0.

Following the transaction, Mahoney beneficially owned 25,035 shares, held directly. The filing indicates it was submitted by an attorney-in-fact on 11/14/2025.

Rhea-AI Summary

Aptiv plc (APTV) — insider transaction: Company officer Katherine H. Ramundo sold 13,000 ordinary shares on 11/10/2025 at $84 each (transaction code S). The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 08/12/2025.

Following the transaction, she beneficially owns 121,959 shares, held directly. Ramundo serves as EVP, CLO, CCO & Secretary.

Rhea-AI Summary

Javed A. Khan, Executive Vice President and President, Software and AS&UX at Aptiv PLC (APTV), reported an insider disposition on 10/01/2025. The filing shows 14,059 ordinary shares were disposed of under transaction code F at a price of $87.1 per share, and the remaining beneficial ownership after the transaction is reported as 198,246 shares. The form states the shares were withheld to satisfy tax liabilities arising from the vesting of restricted stock units. The Form 4 is signed by an attorney-in-fact on behalf of Mr. Khan and dated 10/03/2025.

Rhea-AI Summary

Obed D. Louissaint, EVP & Chief People Officer of Aptiv PLC (APTV), reported a transaction dated 10/01/2025 in which 11,384 ordinary shares were disposed of at a price of $87.1 per share. The filing states the shares were withheld to pay tax liabilities arising from the vesting of restricted stock units. After the reported disposition, Mr. Louissaint beneficially owns 154,871 ordinary shares. The Form 4 was signed on behalf of the reporting person on 10/03/2025.

Rhea-AI Summary

Aptiv PLC officer Allan J. Brazier executed a sale of 1,000 ordinary shares at $85 per share on 09/18/2025 under a Rule 10b5-1 trading plan adopted on 02/11/2025. Following the reported sale, Brazier directly beneficially owns 49,820 shares. The Form 4 was signed on behalf of Brazier by an attorney-in-fact on 09/22/2025. The filing identifies Brazier as an officer (SVP & Chief Accounting Officer) and indicates the transaction was pre-arranged through the 10b5-1 plan.